- Improve accuracy of drug delivery in DPI and pMDI devices
- Prevent drug and carrier particles from sticking to drug flow pathway using antistatic plastics
- Speeds product development with ISO 10993 pretested materials
Imagine thermoplastic compounds that can dramatically improve drug delivery accuracy and reduce static effects on small drug particles. At RTP Company, we
not only imagined them, we’ve made them a reality.
Powdered and aerosol drug formulations that require use of dry powder inhalers (DPI) and pressurized metered dose inhalers (pMDI) often adhere to the drug flow path due to static electricity, resulting in inaccurate dosages. Incorporating PermaStat® compounds into such devices neutralizes the effects of static so that the full dosages reaches the patient.
PermaStat® compounds permanently dissipate static charges independent of ambient humidity. They offer a wide range of features such as clarity, chemical resistance, and colorability all in a clean, non-sloughing compound.
They feature a consistent surface resistivity of 1010 to 1011 ohm/square and have been successfully used in applications requiring biocompatibility, drug interaction, and extraction testing. PermaStat compounds from RTP Company are available in more than 20 different thermoplastic resin systems with transparent options that are available in polypropylene, acrylic, COC, and ABS.
PermaStat® compounds for drug delivery… another innovation from RTP Company: your global compounder of custom engineered thermoplastics.
Innovation Bulletin Download Download a print-friendly PermaStat® Compounds for Drug Delivery innovation bulletin in PDF format.